These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31021670)
1. The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation. Mediouni S; Kessing CF; Jablonski JA; Thenin-Houssier S; Clementz M; Kovach MD; Mousseau G; de Vera IMS; Li C; Kojetin DJ; Evans DT; Valente ST FASEB J; 2019 Jul; 33(7):8280-8293. PubMed ID: 31021670 [TBL] [Abstract][Full Text] [Related]
2. Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat. Mediouni S; Chinthalapudi K; Ekka MK; Usui I; Jablonski JA; Clementz MA; Mousseau G; Nowak J; Macherla VR; Beverage JN; Esquenazi E; Baran P; de Vera IMS; Kojetin D; Loret EP; Nettles K; Maiti S; Izard T; Valente ST mBio; 2019 Feb; 10(1):. PubMed ID: 30723126 [TBL] [Abstract][Full Text] [Related]
3. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment. Kessing CF; Nixon CC; Li C; Tsai P; Takata H; Mousseau G; Ho PT; Honeycutt JB; Fallahi M; Trautmann L; Garcia JV; Valente ST Cell Rep; 2017 Oct; 21(3):600-611. PubMed ID: 29045830 [TBL] [Abstract][Full Text] [Related]
5. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription. Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST mBio; 2019 Jul; 10(4):. PubMed ID: 31266880 [TBL] [Abstract][Full Text] [Related]
6. Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A. Rice AP mBio; 2019 Jul; 10(4):. PubMed ID: 31289189 [TBL] [Abstract][Full Text] [Related]
7. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991 [TBL] [Abstract][Full Text] [Related]
8. Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations. Kleinman AJ; Sivanandham S; Sette P; Sivanandham R; Policicchio BB; Xu C; Penn E; Brocca-Cofano E; Le Hingrat Q; Ma D; Pandrea I; Apetrei C J Virol; 2022 Jun; 96(12):e0044522. PubMed ID: 35638831 [TBL] [Abstract][Full Text] [Related]
9. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy. Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070 [TBL] [Abstract][Full Text] [Related]
10. Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat. Li C; Mousseau G; Valente ST Epigenetics Chromatin; 2019 Apr; 12(1):23. PubMed ID: 30992052 [TBL] [Abstract][Full Text] [Related]
12. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir. Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L mBio; 2017 Aug; 8(4):. PubMed ID: 28811349 [TBL] [Abstract][Full Text] [Related]
13. Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques. Cartwright EK; Palesch D; Mavigner M; Paiardini M; Chahroudi A; Silvestri G J Virol; 2016 Aug; 90(15):6699-6708. PubMed ID: 27170752 [TBL] [Abstract][Full Text] [Related]
14. Infectious Virus Persists in CD4 Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455 [TBL] [Abstract][Full Text] [Related]
16. The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A. Li C; Mori L; Valente ST J Infect Dis; 2021 Feb; 223(12 Suppl 2):46-53. PubMed ID: 33586776 [TBL] [Abstract][Full Text] [Related]
17. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes. Sugimoto C; Tadakuma K; Otani I; Moritoyo T; Akari H; Ono F; Yoshikawa Y; Sata T; Izumo S; Mori K J Virol; 2003 Apr; 77(7):4169-80. PubMed ID: 12634375 [TBL] [Abstract][Full Text] [Related]
18. Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy. Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ohlen C; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF PLoS Pathog; 2017 May; 13(5):e1006359. PubMed ID: 28472156 [TBL] [Abstract][Full Text] [Related]
19. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693 [TBL] [Abstract][Full Text] [Related]
20. Distinct host cell proteins incorporated by SIV replicating in CD4+ T cells from natural disease resistant versus non-natural disease susceptible hosts. Stephenson ST; Bostik P; Song B; Rajan D; Bhimani S; Rehulka P; Mayne AE; Ansari AA Retrovirology; 2010 Dec; 7():107. PubMed ID: 21162735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]